A recent study indicates that patients who stop using new slimming jabs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who stop conventional lifestyle regimens.
Published data in a major health publication demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying these medications must be informed of the potential of fast weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain means a reversion to original weight within about a year and a half.
Comparing Therapies
The research, which examined 37 of trials involving over 9,000 of patients, compared the results of GLP-1 agonists with older methods.
Scientists point out that individuals who lose weight through lifestyle changes alone typically have a less rapid weight regain—around 100 grams monthly—once they finish.
Explaining the Fast Regain
Doctors believe the way of the injections accounts for the heightened rebound.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of GLP-1 concentrations far above than the body's typical production may cause the body to produce less of its endogenous hormone, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making overeating much more probable."
An Ongoing Condition?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.
Professionals say that, due to the likelihood of relapse, the therapy might need to be ongoing.
This view is echoed by drug manufacturers, who say that the results "emphasize the chronic character of excess weight," akin to managing conditions like high blood pressure.
Patient Accounts
People who have come off the medication explain a powerful return of cravings.
"It was like a trigger that goes on and you become ravenous," described one woman.
This challenge is exacerbated if users have not established sustainable lifestyle or habit changes during therapy.
Significant Adoption
Figures suggest that a significant number of people in the UK have tried these injections in the past year, with demand being substantial.
- Adoption is more common among women compared to males.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a standalone cure and lasting health benefits hinges on integrated behavioural changes.
